Education
About Us
Working with TipRanks
Follow Us
Wave Life Sciences Pte. Ltd (WVE)
:WVE
Total Valuation
Wave Life Sciences has a market cap or net worth of $1.05B. The enterprise value is $501.11M.
Market Cap$1.05B
Enterprise Value$501.11M
Share Statistics
Wave Life Sciences has 155,562,670 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding155,562,670
Owned by Insiders27.34%
Owned by Institutions0.10%
Financial Efficiency
Wave Life Sciences’s return on equity (ROE) is -0.46 and return on invested capital (ROIC) is -44.36%.
Return on Equity (ROE)-0.46
Return on Assets (ROA)-0.28
Return on Invested Capital (ROIC)-44.36%
Return on Capital Employed (ROCE)-0.46
Revenue Per Employee377.36K
Profits Per Employee-338.01K
Employee Count287
Asset Turnover0.31
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Wave Life Sciences is -17.63. Wave Life Sciences’s PEG ratio is 0.26.
PE Ratio-17.63
PS Ratio0.00
PB Ratio-12.24
Price to Fair Value8.16
Price to FCF-4.27
Price to Operating Cash Flow-4.32
PEG Ratio0.26
Income Statement
In the last 12 months, Wave Life Sciences had revenue of 108.30M and earned -97.01M in profits. Earnings per share was -0.70.
Revenue108.30M
Gross Profit108.30M
Operating Income-110.40M
Pretax Income-97.01M
Net Income-97.01M
EBITDA-101.74M
Earnings Per Share (EPS)-0.70
Cash Flow
In the last 12 months, operating cash flow was -180.63M and capital expenditures -686.00K, giving a free cash flow of -181.32M billion.
Operating Cash Flow-180.63M
Free Cash Flow-181.32M
Free Cash Flow per Share-1.17
Dividends & Yields
Wave Life Sciences pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.75
52-Week Price Change23.40%
50-Day Moving Average6.72
200-Day Moving Average10.07
Relative Strength Index (RSI)50.08
Average Volume (3m)1.04M
Important Dates
Wave Life Sciences upcoming earnings date is Jul 31, 2025, TBA (Confirmed).
Last Earnings DateMay 8, 2025
Next Earnings DateJul 31, 2025
Ex-Dividend Date―
Financial Position
Wave Life Sciences as a current ratio of 2.89, with Debt / Equity ratio of -83.42%
Current Ratio2.89
Quick Ratio2.89
Debt to Market Cap0.00
Net Debt to EBITDA2.72
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Wave Life Sciences has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Wave Life Sciences EV to EBITDA ratio is -14.09, with an EV/FCF ratio of -9.44.
EV to Sales13.24
EV to EBITDA-14.09
EV to Free Cash Flow-9.44
EV to Operating Cash Flow-9.49
Balance Sheet
Wave Life Sciences has $243.07M in cash and marketable securities with $23.60M in debt, giving a net cash position of -$219.48M billion.
Cash & Marketable Securities$243.07M
Total Debt$23.60M
Net Cash-$219.48M
Net Cash Per Share-$1.41
Tangible Book Value Per Share$1.52
Margins
Gross margin is -177.17%, with operating margin of -101.94%, and net profit margin of -89.57%.
Gross Margin-177.17%
Operating Margin-101.94%
Pretax Margin-89.57%
Net Profit Margin-89.57%
EBITDA Margin-93.94%
EBIT Margin-101.94%
Analyst Forecast
The average price target for Wave Life Sciences is $18.20, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$18.20
Price Target Upside169.63% Upside
Analyst ConsensusStrong Buy
Analyst Count11
Revenue Growth Forecast-7.06%
EPS Growth Forecast-57.17%